RIVASTIGMINE Tartrate Capsules recall: Contamination
RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally 500-900 India, NDC…
Why was RIVASTIGMINE Tartrate Capsules recalled?
Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #C607323, Exp 10/18
- Product
- RIVASTIGMINE Tartrate Capsules, USP, 1.5 mg, 60-count bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally 500-900 India, NDC…
- Recalling firm
- Dr. Reddy's Laboratories, Inc.
- Quantity
- 1,728 bottles
- Distribution
- U.S. nationwide
- Recall date
- April 12, 2017
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)